*6.2.11. Inhibitors of the tumor cell cycle*

In gastric tumors, there is an alteration of cell cycle regulatory mechanisms [173]. Flavopiridol is a cyclin-dependent kinase inhibitor, unfortunately demonstrated to have low efficacy and serious adverse effects in gastric cancer [174]. Because of its low activity as a single agent, it must be investigated in combination with other chemotherapeutics.
